Item Details

Print View

Emerging Health Care Issues: Follow-on Biologic Drug Competition : Hearing Before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, First Session, June 11, 2009

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health
Format
EBook; Book; Government Document; Online
Published
Washington : U.S. G.P.O., 2012.
Language
English
SuDoc Number
Y 4.C 73/8:111-46
Description
1 online resource (vi, 283 pages) : illustrations
Notes
  • Title from title screen (viewed on July 30, 2012).
  • Paper version available for sale by the Supt. of Docs., U.S.G.P.O.
  • "Serial no. 111-46."
  • Includes bibliographical references.
Copyright Not EvaluatedCopyright Not Evaluated
Technical Details
  • Access in Virgo Classic
  • Staff View

    LEADER 02330cam a2200505 a 4500
    001 u5812577
    003 SIRSI
    005 20160825162840.0
    006 m o d f
    007 cr bn||||a||||
    008 120730s2012 dcua ob f000 0 eng c
    019
      
      
    a| 920386170
    037
      
      
    a| 552-070-44875-6 b| GPO f| paper
    035
      
      
    a| (OCoLC)802251373
    040
      
      
    a| GPO b| eng e| pn c| GPO d| GPO d| OCLCQ d| OCLCO d| OCLCE d| OCLCQ d| GPO d| MvI
    042
      
      
    a| pcc a| dlr
    043
      
      
    a| n-us---
    049
      
      
    a| VA@@
    050
    1
    4
    a| KF27 b| .E553 2009i
    074
      
      
    a| 1019-C-01 (online)
    086
    0
      
    a| Y 4.C 73/8:111-46
    088
      
      
    a| Serial no. 111-46 (United States. Congress. House. Committee on Energy and Commerce)
    110
    1
      
    a| United States. b| Congress. b| House. b| Committee on Energy and Commerce. b| Subcommittee on Health.
    245
    1
    0
    a| Emerging health care issues : b| follow-on biologic drug competition : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, first session, June 11, 2009.
    264
      
    1
    a| Washington : b| U.S. G.P.O., c| 2012.
    300
      
      
    a| 1 online resource (vi, 283 pages) : b| illustrations
    336
      
      
    a| text b| txt 2| rdacontent
    337
      
      
    a| computer b| c 2| rdamedia
    338
      
      
    a| online resource b| cr 2| rdacarrier
    500
      
      
    a| Title from title screen (viewed on July 30, 2012).
    500
      
      
    a| Paper version available for sale by the Supt. of Docs., U.S.G.P.O.
    504
      
      
    a| Includes bibliographical references.
    500
      
      
    a| "Serial no. 111-46."
    650
      
    0
    a| Biologicals x| Government policy z| United States.
    650
      
    0
    a| Pharmaceutical biotechnology x| Government policy z| United States.
    650
      
    0
    a| Drugs z| United States v| Patents.
    776
    0
    8
    i| Print version: a| United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. t| Emerging health care issues w| (DLC) 2013379542 w| (OCoLC)805937289
    776
    0
    8
    i| Microfiche version: a| United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. t| Emerging health care issues w| (OCoLC)827788488
    856
    4
    0
    u| http://purl.fdlp.gov/GPO/gpo26033
    596
      
      
    a| 1
    999
      
      
    a| Y 4.C 73/8:111-46 w| SUDOC i| 5812577-1001 l| INTERNET m| UVA-LIB t| INTERNET
▾See more
▴See less

Availability

Google Preview

Google Books Preview

Read Online